Drug Profile
Research programme: galanin-3 receptor antagonists - Lundbeck
Alternative Names: SNAP 37889; SNAP 398299Latest Information Update: 20 Aug 2007
Price :
$50
*
At a glance
- Originator Karolinska Institute; Lundbeck Research USA
- Class
- Mechanism of Action Galanin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder
Most Recent Events
- 29 Jun 2006 Preclinical trials in Anxiety disorders in USA (unspecified route)
- 29 Jun 2006 Preclinical trials in Depression in USA (unspecified route)